Cogent Biosciences (COGT) Revenue & Revenue Breakdown
Cogent Biosciences Revenue Highlights
00
Main Segment (Y)
Preclinical Research And Clinical Development
Main Geography (Y)
Preclinical Research And Clinical Development
Cogent Biosciences Revenue by Period
Cogent Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | -100.00% |
2020-12-31 | - | -65.02% |
2019-12-31 | - | 131.14% |
2018-12-31 | - | 16.44% |
2017-12-31 | - | 31.55% |
2016-12-31 | - | 112.83% |
2015-12-31 | - | - |
Cogent Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | - | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | -100.00% |
2020-09-30 | - | -40.91% |
2020-06-30 | - | -92.49% |
2020-03-31 | - | -54.01% |
2019-12-31 | - | 1398.82% |
2019-09-30 | - | -67.50% |
2019-06-30 | - | 2.78% |
2019-03-31 | - | -19.76% |
2018-12-31 | - | 86.25% |
2018-09-30 | - | 22.63% |
2018-06-30 | - | -24.95% |
2018-03-31 | - | 4.57% |
2017-12-31 | - | -8.92% |
2017-09-30 | - | 12.12% |
2017-06-30 | - | 13.79% |
2017-03-31 | - | - |
Cogent Biosciences Revenue Breakdown
Cogent Biosciences Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 19 | Dec 18 |
---|---|---|
Preclinical Research And Clinical Development | - | - |
Latest
Cogent Biosciences Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 19 | Dec 18 |
---|---|---|
Preclinical Research And Clinical Development | - | - |
Latest
Cogent Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
KNSA | Kiniksa Pharmaceuticals | - | - |
PTGX | Protagonist Therapeutics | - | - |
MRSN | Mersana Therapeutics | - | - |
IDYA | IDEAYA Biosciences | - | - |
ANAB | AnaptysBio | - | - |
MGTX | MeiraGTx | - | - |
FIXX | Q32 Bio | - | - |
LIFE | aTyr Pharma | - | - |
KROS | Keros Therapeutics | - | - |
CGEM | Cullinan Oncology | - | - |
COGT | Cogent Biosciences | - | - |
VRNA | Verona Pharma | - | - |
OLMA | Olema Pharmaceuticals | - | - |
CERE | Cerevel Therapeutics | - | - |
KURA | Kura Oncology | - | - |
SNDX | Syndax Pharmaceuticals | - | - |
VTYX | Ventyx Biosciences | - | - |
LRMR | Larimar Therapeutics | - | - |
SANA | Sana Bio | - | - |
ZNTL | Zentalis Pharmaceuticals | - | - |
KALV | KalVista Pharmaceuticals | - | - |